Neuropathic pain develops normally in mice lacking both Nav1.7 and Nav1.8

被引:167
|
作者
Nassar, Mohammed A.
Levato, Alessandra
Stirling, L. Caroline
Wood, John N.
机构
[1] UCL, Dept Biol, Mol Nocicept Grp, London WC1E 6BT, England
[2] UCL, Dept Biol, London Pain Consortium, London WC1E 6BT, England
来源
MOLECULAR PAIN | 2005年 / 1卷
基金
英国医学研究理事会;
关键词
D O I
10.1186/1744-8069-1-24
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Two voltage gated sodium channel alpha-subunits, Na(v)1.7 and Na(v)1.8, are expressed at high levels in nociceptor terminals and have been implicated in the development of inflammatory pain. Misexpression of voltage-gated sodium channels by damaged sensory neurons has also been implicated in the development of neuropathic pain, but the role of Na(v)1.7 and Na(v)1.8 is uncertain. Here we show that deleting Na(v)1.7 has no effect on the development of neuropathic pain. Double knockouts of both Na(v)1.7 and Na(v)1.8 also develop normal levels of neuropathic pain, despite a lack of inflammatory pain symptoms and altered mechanical and thermal acute pain thresholds. These studies demonstrate that, in contrast to the highly significant role for Na(v)1.7 in determining inflammatory pain thresholds, the development of neuropathic pain does not require the presence of either Na(v)1.7 or Na(v)1.8 alone or in combination.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] The Changes in Expression of NaV1.7 and NaV1.8 and the Effects of the Inhalation of Their Blockers in Healthy and Ovalbumin-Sensitized Guinea Pig Airways
    Kocmalova, Michaela
    Kazimierova, Ivana
    Barborikova, Jana
    Joskova, Marta
    Franova, Sona
    Sutovska, Martina
    MEMBRANES, 2021, 11 (07)
  • [42] Endogenous opioids contribute to insensitivity to pain in humans and mice lacking sodium channel Nav1.7
    Minett, Michael S.
    Pereira, Vanessa
    Sikandar, Shafaq
    Matsuyama, Ayako
    Lolignier, Stephane
    Kanellopoulos, Alexandros H.
    Mancini, Flavia
    Iannetti, Gian D.
    Bogdanov, Yury D.
    Santana-Varela, Sonia
    Millet, Queensta
    Baskozos, Giorgios
    MacAllister, Raymond
    Cox, James J.
    Zhao, Jing
    Wood, John N.
    NATURE COMMUNICATIONS, 2015, 6
  • [43] Influence of combined voltage-gated sodium channel NaV1.7 and NaV1.8 inhibitors on cough in a guinea pig model
    Brozmanova, Mariana
    Buday, Tomas
    Jakusova, Janka
    Melegova, Jana
    Plevkova, Jana
    RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2023, 312
  • [44] Changes in the expression of NaV1.7, NaV1.8 and NaV1.9 in a distinct population of dorsal root ganglia innervating the rat knee joint in a model of chronic inflammatory joint pain
    Strickland, Iain T.
    Martindale, Jo C.
    Woodhams, Peter L.
    Reeve, Alison J.
    Chessell, Iain P.
    McQueen, Daniel S.
    EUROPEAN JOURNAL OF PAIN, 2008, 12 (05) : 564 - 572
  • [45] Navigating a new path to Nav1.7 for pain
    Katie Kingwell
    Nature Reviews Drug Discovery, 2022, 21 : 18 - 18
  • [46] NaV1.7 and pain: contribution of peripheral nerves
    Hoffmann, Tal
    Sharon, Ohad
    Wittmann, Juergen
    Carr, Richard W.
    Vyshnevska, Alina
    De Col, Roberto
    Nassar, Mohammed A.
    Reeh, Peter W.
    Weidner, Christian
    PAIN, 2018, 159 (03) : 496 - 506
  • [47] Upregulation of Nav1.7 by endogenous hydrogen sulfide contributes to maintenance of neuropathic pain
    Tian, Jun-Jie
    Tan, Chao-Yang
    Chen, Qin-Yi
    Zhou, Ying
    Qu, Zu-Wei
    Zhang, Meng
    Ma, Ke-Tao
    Shi, Wen-Yan
    Li, Li
    Si, Jun-Qiang
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2020, 46 (02) : 782 - 794
  • [48] No Gain, No Pain: Nav1.7 as an Analgesic Target
    King, Glenn F.
    Vetter, Irina
    ACS CHEMICAL NEUROSCIENCE, 2014, 5 (09): : 749 - 751
  • [49] Nav1.7 withholds its pain potential
    Kingwell, Katie
    NATURE REVIEWS DRUG DISCOVERY, 2019, 18 (05) : 321 - 323
  • [50] Neuropathic pain associated with Nav1.7 mutations. Clinical picture and treatment
    Doppler, K.
    Sommer, C.
    NERVENARZT, 2013, 84 (12): : 1428 - +